Abstract
a.u. for control, p<0.01, n=6). However, this increase was abolished in the presence of MPG (96±2 a.u., p<0.01). Co-treatment of ceramide with cyclooxygenase inhibitors, 10μM NS 398 or 1μM nimesulide also abolished the cytoprotection afforded by ceramide (cell viability: NS 398 + Cer 66±2% and nimesulide + Cer 66±1%; p<0.01 vs Cer; n=4) and partially decreased the amount of ROS produced by ceramide. Inhibition of other potential ROS-producing systems with NOS inhibitor (L-NAME, 5mM), xanthine oxidase inhibitor (allopurinol, 0.1mM) or NADPH oxidase inhibitor (Cadmium chloride, 1mM) failed to abolish ceramide cytoprotection. In conclusion, these data strongly suggest that ROS production mediated, in part, by cyclooxygenase would play a major role in the cytoprotective effect of ceramide.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.